55 results
Page 2 of 3
8-K
EX-99.2
28qvys30h1vfi
21 Oct 21
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:24pm
8-K
EX-99.1
7sbk e7pe
21 Oct 21
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:24pm
8-K
EX-99.1
ibzat52myz16 upp125w
29 Jul 21
Stock Purchase Agreement
4:15pm
8-K
EX-99.1
wxb5l0
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
8-K
EX-1.1
4tqhfd gq
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
8-K
EX-99.1
hgj0 iaoqnfp3
3 Sep 20
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
7:35am
8-K
EX-99.2
x1v57pt32hpv1
15 Apr 20
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:06pm
8-K
EX-1.1
o52m4uc
15 Apr 20
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:06pm
8-K
EX-99.1
xn2 8zmmxfbv0p0qwi5
15 Apr 20
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:06pm
S-3
EX-1.2
w3joqy
13 Aug 19
Shelf registration
4:36pm
DEF 14A
ueu0bxo28j i259abm
29 Apr 19
Definitive proxy
12:00am
424B4
ssv43p24g 1ljvc5
18 Jul 18
Prospectus supplement with pricing info
5:27pm
S-1/A
62b6 3chppn56afw
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
EX-10.8
sht3v9mgvhqy nax2h
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
EX-1.1
tlfcv
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
EX-10.1
7q6qgve7e vp9u
9 Jul 18
IPO registration (amended)
6:10am
S-1
EX-4.2
68he umgle
22 Jun 18
IPO registration
4:07pm